Australia's largest stock trading and investment forum Australia's #1 stock forum

CYP

Click for more information

2.17%

22.5¢ cynata therapeutics limited

Ann: Appendix 4D & Half-Year Financial Statements, page-42

First 42 Last

Share
Profile

Follow
Sector

35,472 Posts.

2863

03/03/23

10:04

Post #: 66578202
Share

Originally posted by Pledge: ↑

Ok, here we go.....

Cash = $16.4M
Commitments for next 12 months approx = $4M
Costs outside of R&D and marketing approx = $4.4M

Pledge's estimate costs needed in the next 12 months to commence the GVHD P2 FDA trial only (nothing else) = $8M (inclusive of US exchange rate).

If CYP deliver on the GVHD promise and aren't able to get anyone to pay for the trial, then there is $0 in 12 months.

Notes:

1. I am being conservative. And broad - I have not touched any other costs.
2. I actually believe they will need AU$10M to deliver on the promise of the GVHD P2 FDA trial (I rounded down). I also think doing it remotely will add another 30% to that but let's run with what we have.
3. At record lows a CR in the next 12 months would be disastrous.
4. Given all of the above at best you come out of this with $0 and a completed P2 trial.
5. I would be asking how the hunt for a sponsor to pay for the promises is going? Not much of a mention in this report for something that is critical.
6. I wish shareholders luck. Even Hector.

Expand

@Pledge
lots of homework there on GvHD costs next 12 months for a trial you have claimed for well over a year was never going to happen

Interesting

No Office

Mark it down

Last edited by Sector: 03/03/23

CYP Price at posting: 29.0¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

JDO

Timing will be everything for 'smashing' Hot Stock tip Judo Capital Holdings

RBA holds rates as ALP election campaigning kicks off – expect more political focus

HVN

Harvey Norman may appeal ASIC Federal Court case – the third lawsuit on its plate

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

There are more pages in this discussion • 111 more messages in this thread...

First 42 Last

Add CYP (ASX) to my watchlist

(20min delay)
Last 22.5¢		Change -0.005(2.17%)		Mkt cap ! $40.65M

Open	High	Low	Value	Volume
23.0¢	23.0¢	22.5¢	$33.56K	147.7K

Buyers (Bids)

No.	Vol.	Price($)
4	17952	22.0¢

Sellers (Offers)

Price($)	Vol.	No.
22.5¢	19135	1

View Market Depth

No.	Vol.	Price($)
4	17952	0.220
2	51511	0.215
3	34250	0.210
1	48780	0.205
2	28750	0.200

Price($)	Vol.	No.
0.225	19135	1
0.235	42000	1
0.240	24000	3
0.250	19000	1
0.260	2000	1

Last trade - 15.39pm 05/11/2024 (20 minute delay)

CYP (ASX) Chart